These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6494585)

  • 1. In vitro characterization of new antiestrogens in human mammary tumor cells.
    Eppenberger U; Küng W; Löser R; Roos W
    Recent Results Cancer Res; 1984; 94():245-52. PubMed ID: 6494585
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
    Müller V; Jensen EV; Knabbe C
    Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
    Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
    Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological action of the antiestrogen ICI 164.384 in the MCF-7 mammary cancer cell line].
    Gelly C; Pasqualini JR
    Pathol Biol (Paris); 1989 Sep; 37(7):824-6. PubMed ID: 2631031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity.
    Dumont JA; Bitonti AJ; Wallace CD; Baumann RJ; Cashman EA; Cross-Doersen DE
    Cell Growth Differ; 1996 Mar; 7(3):351-9. PubMed ID: 8838865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.
    Katzenellenbogen BS; Miller MA; Mullick A; Sheen YY
    Breast Cancer Res Treat; 1985; 5(3):231-43. PubMed ID: 4027393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
    Zajchowski DA; Sager R; Webster L
    Cancer Res; 1993 Oct; 53(20):5004-11. PubMed ID: 8402691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
    Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J
    Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
    Herman ME; Katzenellenbogen BS
    J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens.
    Hua W; Christianson T; Rougeot C; Rochefort H; Clinton GM
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):279-89. PubMed ID: 8541224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment.
    Lykkesfeldt AE; Larsen SS; Briand P
    Int J Cancer; 1995 May; 61(4):529-34. PubMed ID: 7759159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC; Katzenellenbogen BS
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens.
    Vignon F; Bouton MM; Rochefort H
    Biochem Biophys Res Commun; 1987 Aug; 146(3):1502-8. PubMed ID: 3304294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications.
    Moreno-Cuevas JE; Sirbasku DA
    In Vitro Cell Dev Biol Anim; 2000; 36(7):410-27. PubMed ID: 11039493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific estrogen receptor binding and biological effects of 16 alpha-iodoestradiol on human breast cancer cells.
    Lippman ME; Do HM; Hochberg RB
    Cancer Res; 1981 Aug; 41(8):3150-4. PubMed ID: 7248972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of tamoxifen and new antiestrogens on estrogen receptor positive and negative breast cancer cells.
    Coradini D; Biffi A; Cappelletti V; Di Fronzo G
    Anticancer Res; 1994; 14(3A):1059-64. PubMed ID: 8074450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.
    Watts CK; Sweeney KJ; Warlters A; Musgrove EA; Sutherland RL
    Breast Cancer Res Treat; 1994; 31(1):95-105. PubMed ID: 7981461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.